José Ignacio Vela Segarra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
José Ignacio Vela Segarra has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Jaume Crespí Vilimelis
Department of Ophthalmology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
1 shared publicationMohammed Alhayek
Department of Ophthalmology Hospital de la Santa Creu i Sant Pau Barcelona Spain
1 shared publicationNuria Torrell Belzach
Department of Ophthalmology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 13 October 2020
- Published by S. Karger AG in Case Reports in Ophthalmology
- Vol. 11 (3) , 528-533
Bilateral Macular Hole Related to Tamoxifen Low-Dose Toxicity
Bilateral macular hole is a rare secondary effect of tamoxifen, a condition which is probably underdiagnosed. We describe the case of a 63-year-old woman who had received low-dose treatment with tamoxifen for 10 years. She presented with a best-corrected visual acuity of 20/40 in both eyes and bilateral macular hole with posterior hyaloid attachment. No reflective deposits were observed. A 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade was performed in the right eye with no anatomical or functional improvement. The most accepted mechanism of macular hole related to tamoxifen is Müller cell toxicity with retinal tissue loss. Therefore, it seems that the standard procedure used in idiopathic macular hole is not the optimal choice, due to a different pathogenic mechanism.
- 13 October 2020
- Published by S. Karger AG in Case Reports in Ophthalmology
- Vol. 11 (3) , 528-533
Open AccessBilateral Macular Hole Related to Tamoxifen Low-Dose Toxicity
Bilateral macular hole is a rare secondary effect of tamoxifen, a condition which is probably underdiagnosed. We describe the case of a 63-year-old woman who had received low-dose treatment with tamoxifen for 10 years. She presented with a best-corrected visual acuity of 20/40 in both eyes and bilateral macular hole with posterior hyaloid attachment. No reflective deposits were observed. A 23-gauge pars plana vitrectomy with internal limiting membrane peeling and gas tamponade was performed in the right eye with no anatomical or functional improvement. The most accepted mechanism of macular hole related to tamoxifen is Müller cell toxicity with retinal tissue loss. Therefore, it seems that the standard procedure used in idiopathic macular hole is not the optimal choice, due to a different pathogenic mechanism.